Arkolith/Insider Trading/ATRA/Form 4

Henrich Jill

EVP, Global Head RA & QualityAtara Biotherapeutics, Inc. (ATRA) · full profile →Form 4 · filed Mar 6, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3K
Net Open-Market Flow
-$3K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2024Sell(S)4K$0.72$3K555K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-24-000907) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML